The examination of the gene expression levels of RUVBL1/2 in different cancer types, as reported in the Gene Expression Profiling Interactive Analysis (GEPIA) database showed that RUVBL1/2 were generally overexpressed in cancers and seemed to be preferentially overexpressed in B-cell lymphoma and thymoma (Supplementary Fig. 8c). The gene discussed is RUVBL1; the disease is thymoma.